comparemela.com
Home
Live Updates
SEC approval for Bharat Biotechs COVID booster intranasal vaccine phase 3 trials : comparemela.com
SEC approval for Bharat Biotech's COVID booster intranasal vaccine phase 3 trials
The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials
Related Keywords
Hyderabad
,
Andhra Pradesh
,
India
,
New Delhi
,
Delhi
,
Bharat
,
,
Experts Committee
,
Subject Experts Committee
,
Drug Controller General
,
Bharat Biotech
,
Bharat Biotech Vaccine
,
Bharat Biotech Covid Vaccine
,
Bharat Biotech Intranasal Vaccine
,
Bharat Biotech Intranasal Covid Vaccine
,
Harat Biotech Covid Intranasal Vaccine
,
Ntranasal Vaccine Bharat Biotech
,
Ntranasal Covid Vaccine Bharat Biotech
,
Bharat Biotech Covaxin
,
Covaxin Covid Vaccine
,
Harat Biotech Covaxin Covid Vaccine
,
Ovaxin Covid Vaccine Bharat Biotech
,
comparemela.com © 2020. All Rights Reserved.